SPECIAL REPORT

Healthy Horizons
A brand new series of weekly segments which will explore the macro and micro issues facing the global economy.

LATEST FROM OUR BLOGS

» More

- Facebook: The Song — Yes, We're Serious

TOP HEADLINES

» Markets | Economy | Companies

- Euro Zone May Be Unprepared For Greek Exit: Belgian Official

PHARMA'S MARKET VIDEO

» More

Wall Street Protests 29 Apr 2010
Following a big demonstration in favor of financial regulation right outside the NYSE, with CNBC's Mike Huckman.
March on Wall Street 29 Apr 2010
Main Street takes to Wall Street today with thousands of union community activists marching to make the big banks pay, with CNBC's Mike Huckman.
Mike Huckman: Reporter's Reporter 29 Apr 2010
Original air date, June 26, 2002.
SBUX Beats the Street 21 Apr 2010
CNBC's Mike Huckman has Starbucks' earnings breakdown.

The Orange Squeeze on Dimon

16 Apr 2010

Some students at Syracuse University have a different idea rather than having JPMorgan's chairman/CEO Jamie Dimon deliver this year's commencement speech, reports CNBC's Mike Huckman.

Nasdaq Outperforms 14 Apr 2010
The Nasdaq easily outperforming the other major indexes today, with CNBC's Mike Huckman.

RSS FEED

» Help

Subscribe to this RSS feed
Stay up to date with Pharma's Market.

Pharma's Market

Text Size

Jan.12

1:35 PM ET

Monday, 12 Jan 2009

Is Roche In A Rush For Genentech?

Posted By:Mike Huckman

Topics:Stock Market | Medicine | Corporate News | CEOs and CFOs | Pharmaceuticals

Sectors:Insurance | Health Care Equipment and Services | Health Care | Pharmaceuticals

Companies:JPMorgan Chase and Co | Genentech, Inc. | Pfizer Inc

Roche CFO's presentation at the JPMorgan Healthcare Conference
CNBC.com
Roche CFO's presentation at the JPMorgan Healthcare Conference
Not surprisingly it was standing room only in the grand ballroom of the Westin St. Francis Hotel in San Francisco for the Roche presentation this morning at the JPMorgan Healthcare Conference[JPM Loading... () ] .

You'd expect high interest after the "Financial Times" reported last Friday afternoon that the Swiss drugmaker is going to up its bid for Genentech.

Roche CFO Erich Hunziker didn't talk about that. But he did say, "We see very clearly that we will not touch innovation (at Genentech), but there's a lot of synergies we can win in this market."

He acknowledged the "fear" that Roche will "destroy" Genentech [DNA Loading... () ] , especially here in the Bay Area where DNA is headquartered, but Hunziker said, "The cuts we will do at the Roche side are much tougher that what we will do at the Genentech side."

Overflow crowd at breakout roche session
CNBC.com
Overflow crowd at breakout roche session
The crowd for the Roche breakout session where the q and a takes place was so big I couldn't get in.

I found it curious that there were three bylines (reporter names) on the FT story, but no attribution whatsoever. No "a source familiar with the situation" or "according to people who are close to the negotiations," etc. I could never go on air without attributing that kind of information even to an anonymous source.

Anyway, Genentech CEO Art Levinson presents tomorrow at 5:30 ET. The company reports earnings after the closing bell this Thursday, so don't expect him to say much here tomorrow. Like Roche, Genentech has been pretty tight-lipped about all this.

At the time of DNA's presentation I will be on "Fast Money" for a live interview with athenahealth CEO Jonathan Bush. ATHN [ATHN Loading... () ] is an electronic medical records company that hopes to benefit from President-elect Obama's plan to digitize all the doctors' paperwork.